Effectiveness of Different Preventive Regimens in Cariogram Parameters and DMF Scores of High Caries Risk Patients: A Randomized Control Trial

Sponsor
Cairo University (Other)
Overall Status
Unknown status
CT.gov ID
NCT04032184
Collaborator
(none)
66
1
3
13
5.1

Study Details

Study Description

Brief Summary

66 Participants will be divided into three groups according to the tested regimen (A), where (A1) represents participants exposed to fluoride toothpaste, (A2) represents participants exposed to regimen including fluoride toothpaste and chlorhexidine mouthwash and (A3) represents participants exposed to regimen including fluoride toothpaste, chlorhexidine mouthwash and MI fluoride varnish. The study will be carried over a period of one year, assessment of cariogram will be done in two visits: first visit (baseline: T0) and second visit (after 3 months: T2). In addition assessment of DMF scores will be done in four visits: first visit (baseline: T0), second visit (after 3 months: T1), third visit (after 6 months: T2) and final visit (after 12 months: T3) to obtain the required data

Condition or Disease Intervention/Treatment Phase
  • Other: Fluoride toothpaste
  • Other: fluoride toothpaste and chlorhexidine mouthwash
  • Other: fluoride toothpaste, chlorhexidine mouthwash, MI varnish
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
66 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Effectiveness of Different Preventive Regimens in Cariogram Parameters and DMF Scores of High Caries Risk Patients: A Randomized Control Trial
Anticipated Study Start Date :
Oct 1, 2019
Anticipated Primary Completion Date :
Oct 1, 2020
Anticipated Study Completion Date :
Nov 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Fluoride toothpaste

Other: Fluoride toothpaste
regimen using fluoride toothpaste

Experimental: fluoride toothpaste and chlorhexidine mouthwash

Other: fluoride toothpaste and chlorhexidine mouthwash
regimen using fluoride toothpaste and chlorhexidine mouthwash

Experimental: fluoride toothpaste, chlorhexidine mouthwash, MI varnish

Other: fluoride toothpaste, chlorhexidine mouthwash, MI varnish
regimen using fluoride toothpaste, chlorhexidine mouthwash, MI varnish

Outcome Measures

Primary Outcome Measures

  1. Caries Risk Assessment [an average 3 months]

    will be evaluated by cariogram

Secondary Outcome Measures

  1. DMF scores [an average of 12 months]

    will be evaluated by ICDAS

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age range 20-50 years

  • High caries risk patients defined according to cariogram caries risk assessment model

  • On non-cariogenic diet

  • High plaque index

  • Systematically healthy

  • No orthodontic or prosthodontic appliance

Exclusion Criteria:
  • Age range less than 20 or more than 50 years

  • Low or moderate caries risk patients according to cariogram

  • Patients with a compromised medical history

  • Cariogenic diet patient

  • Participants with a history of allergy to any of the drugs or chemicals used in the study

  • Patients on any antibiotics during the past month

Contacts and Locations

Locations

Site City State Country Postal Code
1 Howaida Fakhry Fouad Giza Other Egypt 8655

Sponsors and Collaborators

  • Cairo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Howaida Fakhry Fouad, Resident of conservative departement , Faculty of Oral and Dental Medicine, Cairo university 2012, Cairo University
ClinicalTrials.gov Identifier:
NCT04032184
Other Study ID Numbers:
  • 1234567
First Posted:
Jul 25, 2019
Last Update Posted:
Jul 25, 2019
Last Verified:
Jul 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 25, 2019